← Back to All Stocks

I-Mab (IMAB) Analysis

Generated on: 2025-07-16 15:37:41 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$2.09
Predicted Price
$1.64
Expected Return
-18.65%
Confidence Score
0.86
RSI (14)
37.90
MACD
0.05
Volume
103,617
Float Shares
97,017,799
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

IMAB

I-Mab
-18.65%
Price: $2.09
Confidence: 0.86
News
Last updated: 2025-07-16 15:37:40

Technical Analysis

RSI: 37.90
MACD: 0.05
Technical Analysis Graph

Risk Analysis

Volatility
111.39%
Max Drawdown
-61.25%
Beta
1.0
Risk Score
89.1

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
I-Mab Presents Promising Phase 1b Givastomig Combination Data for Gastric Cancers at ESMO GI 2025
Insider Monkey - 2025-07-09 11:20
I-Mab (NASDAQ:IMAB) is one of the best-performing NASDAQ stocks according to analysts. On July 2, I-Mab announced the presentation of positive Phase 1b combination data for givastomig at the European Society for Medical Oncology Gastrointestinal Cancers Congress 2025 (ESMO GI 2025) in Barcelona. Givastomig, which is a bispecific antibody that targets Claudin 18.2 (CLDN18.2) and […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.